Role of Nutrition, Gene Polymorphism, and Gut Microbiota in Non-alcoholic Fatty Liver Disease

被引:0
|
作者
Kong, Lingbo [1 ]
Lu, Yu [1 ]
Zhang, Siyu [1 ]
Nan, Yuemin [1 ]
Qiao, Liang [2 ]
机构
[1] Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Shijiazhuang 050051, Hebei, Peoples R China
[2] Univ Sydney, Westmead Hosp, Westmead Millennium Inst Med Res, Storr Liver Ctr, Westmead, NSW 2145, Australia
关键词
HEPATIC STELLATE CELLS; VITAMIN-D DEFICIENCY; SUPERFAMILY MEMBER 2; INSULIN-RESISTANCE; OXIDATIVE STRESS; HISTOLOGICAL SEVERITY; TRANSCRIPTION FACTORS; FRUCTOSE CONSUMPTION; METABOLIC SYNDROME; COPPER DEFICIENCY;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. The nutrients play important roles in the development and progression of NAFLD. High-calorie diet, especially the diet rich in saturated fatty acids and cholesterol, as well as sugary drinks with high fructose content, induces hepatic steatosis and triggers progression of steatohepatitis, fibrosis, and even hepatocellular carcinoma. Disordered micronutrient status and gut microbiota are also involved in the pathogenesis of NAFLD. Nutrients related NAFLD could be aggravated by a genetic predisposition, for instance, genetic mutations in patatinlike phospholipase domain-containing 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2). Reduction of caloric intake through lifestyle interventions and use of dietary supplements such as omega-3 fatty acids, vitamins, and probiotics may help alleviate liver injury in NAFLD.
引用
收藏
页码:95 / 106
页数:12
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria
    Katherine J. P. Schwenger
    Colin M. Bolzon
    Carrie Li
    Johane P. Allard
    European Journal of Nutrition, 2019, 58 : 1771 - 1784
  • [32] The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
    Houttu, Veera
    Boulund, Ulrika
    Grefhorst, Aldo
    Soeters, Maarten R.
    Pinto-Sietsma, Sara-Joan
    Nieuwdorp, Max
    Holleboom, Adriaan G.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [33] The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management
    Berna, Genoveva
    Romero-Gomez, Manuel
    LIVER INTERNATIONAL, 2020, 40 : 102 - 108
  • [34] The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
    Ni, Yiming
    Lu, Mengna
    Xu, Yuan
    Wang, Qixue
    Gu, Xinyi
    Li, Ying
    Zhuang, Tongxi
    Xia, Chenyi
    Zhang, Ting
    Gou, Xiao-jun
    Zhou, Mingmei
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [35] Gut Dysfunction and Non-alcoholic Fatty Liver Disease
    Grabherr, Felix
    Grander, Christoph
    Effenberger, Maria
    Adolph, Timon Erik
    Tilg, Herbert
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [36] Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
    Han, Ruiting
    Ma, Junli
    Li, Houkai
    FRONTIERS OF MEDICINE, 2018, 12 (06) : 645 - 657
  • [37] Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease
    Bakhshimoghaddam, Farnush
    Alizadeh, Mohammad
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (02) : 223 - 226
  • [38] Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis
    Tang, Ruiqi
    Liu, Rongrong
    Zha, Hua
    Cheng, Yiwen
    Ling, Zongxin
    Li, Lanjuan
    ENGINEERING IN LIFE SCIENCES, 2024, 24 (05):
  • [39] Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
    Demir, Muenevver
    Lang, Sonja
    Martin, Anna
    Farowski, Fedja
    Wisplinghoff, Hilmar
    Vehreschild, Maria J. G. T.
    Krawczyk, Marcin
    Nowag, Angela
    Scholz, Claus Jurgen
    Kretzschmar, Anne
    Roderburg, Christoph
    Lammert, Frank
    Goeser, Tobias
    Kasper, Philipp
    Steffen, Hans-Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (11) : 1969 - 1977
  • [40] Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
    Ruiting Han
    Junli Ma
    Houkai Li
    Frontiers of Medicine, 2018, 12 : 645 - 657